The global infection control market is experiencing robust growth, with revenues estimated at $50.0 billion in 2022 and projected to reach $58.3 billion by 2027, representing a steady CAGR of 3.1% during the forecast period. This growth is driven by several factors, including the increasing outsourcing of sterilization services, a rising number of surgical procedures, a growing geriatric population, and the subsequent increase in the incidence of chronic diseases.
Download PDF Brochure-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1084
High Incidence of Hospital-Acquired Infections (HAIs): Hospital-acquired infections (HAIs) are a significant global concern, causing morbidity and mortality among patients. These infections encompass various types, such as pneumonia, surgical-site infections, and urinary tract infections, often caused by contaminated medical devices. The prevalence of HAIs is a major driver of the infection control market.
Adverse Effects of Chemical Disinfectants: Chemical disinfectants, while effective against pathogens, often have toxic properties and can be harmful to the environment and cleaning personnel. Regulatory oversight, such as registration with the Environmental Protection Agency (EPA), is required for these disinfectants. Finding safer alternatives poses a challenge.
Growing Healthcare Industry and Outsourcing: Emerging economies like India, Brazil, China, and South Africa present opportunities for sterilization and disinfection markets. The need for improved healthcare services, driven by aging populations and rising incomes, creates a favorable environment for infection control services.
Development of Alternative Technologies: Novel technologies like electrolyzed water, cold atmospheric pressure plasma, self-disinfecting surfaces, and no-touch decontamination methods are being developed as alternatives to traditional surface disinfection techniques. These innovations may disrupt the market in the future.
Protective Barriers Segment: Protective barriers, including medical nonwovens, gloves, covers, closures, goggles, and face masks, account for the largest share in the infection control market. Their adoption is driven by their use in various surgical procedures and increasing awareness of infection control.
Sterilization Equipment Segment: In the sterilization products and services category, sterilization equipment is expected to register the highest growth rate. Factors contributing to this growth include cost-effectiveness and ease of setup.
Medical Nonwovens: Within protective barriers, medical nonwovens dominate due to their use in surgeries, preference for single-use products, and heightened awareness of health issues.
Hospitals and Clinics: The hospitals and clinics segment is expected to experience the highest growth among end-users due to the increasing prevalence of HAIs, the rise in surgical procedures, and the expansion of healthcare facilities in Asian countries.
North America: North America leads the infection control market, driven by a growing geriatric population, stringent regulations, advanced healthcare infrastructure, and the adoption of newer surface disinfectants.
Prominent players in the infection control market include Steris Plc, Getinge AB, Ecolab, 3M Company, Advanced Sterilization Products, Sotera Health Company, MMM Group, Matachana Group, Belimed AG, Metrex Research LLC, Reckitt Benckiser, Pal International, Melag Medizintechnik GmbH & Co. KG, The Miele Group, Systec GmbH, Contec, and Continental Equipment Company.
The global infection control market is on a growth trajectory, fueled by the need to combat hospital-acquired infections, the development of innovative technologies, and the expansion of healthcare services in emerging economies. While challenges such as the adverse effects of chemical disinfectants persist, opportunities in healthcare outsourcing and the adoption of safer sterilization and disinfection methods promise a promising future for the industry.